Kaddah et al. reported that β-thalassemia major and β-thalassemia intermedia patients have high serum hepcidin and concluded that information on hepcidin levels in patients with β-thalassemia may help in identifying the most severely affected patients and predicting and monitoring parenchymal iron overload [20]. The gene discussed is HAMP; the disease is Tangier disease.